Monitor for actual sale on Form 4. The resignation from the board combined with this sale could signal reduced insider confidence, but the amount is small relative to market cap. No immediate catalyst expected.
Price Chart
Executive Summary
Former board member Richard A. Heyman filed a Form 144 notice of intent to sell 38,000 shares of Enliven Therapeutics (ELVN), valued at approximately $2.25 million. Heyman recently resigned from the board of directors. The shares were acquired via stock option exercise and restricted stock purchase in 2020. The sale is to be executed through Fidelity Brokerage Services.
Key Facts
- Richard A. Heyman, former board member, filed Form 144 to sell 38,000 shares (~$2.25M)
- Heyman resigned from the board of directors
- Shares acquired via stock option exercise (10/23/2020) and restricted stock purchase (01/28/2020)
- Sale to be executed through Fidelity Brokerage Services LLC
- Filing date: September 4, 2026
Financial Impact
Proposed sale of 38,000 shares valued at ~$2.25M, representing approximately 0.05% of ELVN's $4.4B market cap
Risk Factors
- Potential insider selling pressure if the sale is executed
- Perception of reduced confidence from a former board member
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (ELVN) — Batch item 1 | 0001959173-26-006749 |
| Document: 0001959173-26-006749-index.html | 0001959173-26-006749 |
| Document: 0001959173-26-006749.txt | 0001959173-26-006749 |
| 144 Filing (ELVN) — Batch item 4 | 0001959173-26-006749 |
| Document: 0001959173-26-006749-index.html | 0001959173-26-006749 |
| Document: 0001959173-26-006749.txt | 0001959173-26-006749 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | Insider Cluster | $41.93 | awaiting T+5 | — | $41.49 (−1.05%) |
Oct 19, 2026 7d ago | 144 | $41.25 | awaiting T+5 | — | $41.49 (+0.58%) |
Oct 16, 2026 10d ago | 3 | $38.70 $41.49 | ▲ +7.21% | ▲ +7.35% | $41.49 (+7.21%) |
Oct 14, 2026 12d ago | 8-K | $39.33 $41.93 | ▲ +6.61% | ▲ +7.63% | $41.49 (+5.49%) |
Sep 21, 2026 5w ago | Insider Cluster | $48.19 $46.51 | ▼ −3.49% | ▼ −2.30% | $41.49 (−13.90%) |
Sep 4, 2026 7w ago | 144 | $59.32 $54.43 | ▼ −8.24% | ▼ −7.03% | $41.49 (−30.06%) |
Aug 19, 2026 9w ago | Insider Cluster | $58.97 $60.50 | ▲ +2.59% | ▲ +1.48% | $41.49 (−29.64%) |
Aug 9, 2026 11w ago | Institutional Cluster | $59.42 $59.54 | ▲ +0.19% | ▲ +0.24% | $41.49 (−30.18%) |
Jul 21, 2026 13w ago | Insider Cluster | $52.85 $52.97 | ▲ +0.23% | ▲ +2.63% | $41.49 (−21.49%) |
Jun 22, 2026 17w ago | 144 | $48.60 $50.85 | ▲ +4.63% | ▲ +3.62% | $41.49 (−14.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers